Extensive research over the years has suggested that alterations in PDE expression and function, and subsequent variations in cyclic nucleotide levels and their downstream targets, might contribute to several movement disorders such as Huntington's disease (HD)4, 5 and Parkinson's disease (PD).5, 6. This evidence concerns the gene ALDH7A1 and movement disorder.